Evidence map›Paper›PMID 26963625›Full record

ArticlePLoS genetics2016

Cdkn1c Boosts the Development of Brown Adipose Tissue in a Murine Model of Silver Russell Syndrome.

Matthew Van De Pette, Simon J Tunster, Grainne I McNamara, Tatyana Shelkovnikova, Steven Millership, Lindsay Benson, Stuart Peirson, Mark Christian, Antonio Vidal-Puig, Rosalind M John

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Role of CDKs and CDKIs in Murine Development.International journal of molecular sciences · 2020
    Review
  9. Review
  10. Review
  11. Article
  12. Genomic imprinting and its effects on postnatal growth and adult metabolism.Cellular and molecular life sciences : CMLS · 2019
    Review
  13. Article
  14. Article
  15. Loss of Imprinting ofInternational journal of molecular sciences · 2018
    Article
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Matthew Van De PetteSchool of Biosciences, Cardiff University, Cardiff, United Kingdom.
Simon J TunsterSchool of Biosciences, Cardiff University, Cardiff, United Kingdom.
Grainne I McNamaraSchool of Biosciences, Cardiff University, Cardiff, United Kingdom.
Tatyana ShelkovnikovaSchool of Biosciences, Cardiff University, Cardiff, United Kingdom.
Steven MillershipMRC Clinical Sciences Centre, Hammersmith Hospital, London, United Kingdom.
Lindsay BensonNuffield Department of Clinical Neuroscience, Nuffield Laboratory of Ophthalmology, John Radcliffe Hospital, Oxford, United Kingdom.
Stuart PeirsonNuffield Department of Clinical Neuroscience, Nuffield Laboratory of Ophthalmology, John Radcliffe Hospital, Oxford, United Kingdom.
Mark ChristianDivision of Translational and Systems Medicine, Warwick Medical School, University of Warwick, Coventry, United Kingdom.
Antonio Vidal-PuigMetabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.
Rosalind M JohnSchool of Biosciences, Cardiff University, Cardiff, United Kingdom.
Cardiff University · GBJohn Radcliffe Hospital · GBAddenbrooke's Hospital · GBHammersmith Hospital · GBUniversity of Warwick · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F016557Biotechnology and Biological Sciences Research Council BB/G015465/1Biotechnology and Biological Sciences Research Council BB/J015156British Heart Foundation PG/12/53/29714Medical Research Council G0400155Medical Research Council MC_G0802535Medical Research Council MC_UU_12012/2Medical Research Council MR/M013960/1
6 · The paper itself

Abstract

The accurate diagnosis and clinical management of the growth restriction disorder Silver Russell Syndrome (SRS) has confounded researchers and clinicians for many years due to the myriad of genetic and epigenetic alterations reported in these patients and the lack of suitable animal models to test the contribution of specific gene alterations. Some genetic alterations suggest a role for increased dosage of the imprinted CYCLIN DEPENDENT KINASE INHIBITOR 1C (CDKN1C) gene, often mutated in IMAGe Syndrome and Beckwith-Wiedemann Syndrome (BWS). Cdkn1c encodes a potent negative regulator of fetal growth that also regulates placental development, consistent with a proposed role for CDKN1C in these complex childhood growth disorders. Here, we report that a mouse modelling the rare microduplications present in some SRS patients exhibited phenotypes including low birth weight with relative head sparing, neonatal hypoglycemia, absence of catch-up growth and significantly reduced adiposity as adults, all defining features of SRS. Further investigation revealed the presence of substantially more brown adipose tissue in very young mice, of both the classical or canonical type exemplified by interscapular-type brown fat depot in mice (iBAT) and a second type of non-classic BAT that develops postnatally within white adipose tissue (WAT), genetically attributable to a double dose of Cdkn1c in vivo and ex-vivo. Conversely, loss-of-function of Cdkn1c resulted in the complete developmental failure of the brown adipocyte lineage with a loss of markers of both brown adipose fate and function. We further show that Cdkn1c is required for post-transcriptional accumulation of the brown fat determinant PR domain containing 16 (PRDM16) and that CDKN1C and PRDM16 co-localise to the nucleus of rare label-retaining cell within iBAT. This study reveals a key requirement for Cdkn1c in the early development of the brown adipose lineages. Importantly, active BAT consumes high amounts of energy to generate body heat, providing a valid explanation for the persistence of thinness in our model and supporting a major role for elevated CDKN1C in SRS.

Indexed as

Genomic ImprintingAdipose Tissue, BrownAdipose Tissue, WhiteAdultAnimalsBody TemperatureCyclin-Dependent Kinase Inhibitor p57Disease Models, AnimalDNA-Binding ProteinsHumansMiceMitochondriaMutationPhenotypeSilver-Russell SyndromeTranscription FactorsCdkn1c protein, mouseCyclin-Dependent Kinase Inhibitor p57DNA-Binding ProteinsPrdm16 protein, mouseTranscription Factors

Identifiers

PMID26963625
PMCPMC4786089
OpenAlexW2294658361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.